According to Dr. Mark Hamilton from Atlanta, Georgia, who has always been interested in cardiovascular disease and has been dealing with it on a daily basis.
When Bios Life was introduced in February 2006, Dr. Mark was very impressed with the initial results but as his nature was quite skeptical, he has spent hundreds of hours researching the data.
Statin drugs has been designated as the first line therapy to reduce cardiovascular disease risk and it has been extremely effective in lowering LDL cholesterol. What is less well known is that even with maximum dosage of statins to lower LDL cholesterol, only 30% of cardiovascular disease risk is reduced.
Other components of the lipid profile list are now also being addressed. HDL cholesterol and Triglycerides are now receiving attention as being just as important as LDL cholesterol. The mantra over the next 10 years will be combination therapy and statins of mono therapy will only reduce risk of 30%. Combination therapy will become more and more popular.
Bios Life, a natural combination therapy, with 4 mechanisms of action, has shown to:
- Lower LDL cholesterol by an average of 31% (in line with the statins)
- Increase HDL cholesterol by an average of 29%
- Decrease Triglycerides to a maximum of 40%
Combination therapy therefore will be the mantra and is the way for the future. Bios Life is perfectly placed as the natural, 4 mechanisms, combination therapy that impacts the entire lipid profile.
